Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


INTERVIEW: Ex-Pfizer Exec Esen Talks Turkey, China

This article was originally published in PharmAsia News

Executive Summary

The Turkish pharmaceutical industry started 2016 with ongoing worries about the negative impact of basic government policies, while at the same time companies have hopes for the future given an increased official emphasis on high technology and the production of high-value drugs. Ahmet Esen, a partner at ASBIO Consultancy and former international senior manager at Pfizer, answers PharmAsia News’s questions about the prospects for the industry in the country.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts